Literature DB >> 32881497

Metabolic Forest: Predicting the Diverse Structures of Drug Metabolites.

Tyler B Hughes1, Na Le Dang1, Ayush Kumar1, Noah R Flynn1, S Joshua Swamidass1.   

Abstract

Adverse drug metabolism often severely impacts patient morbidity and mortality. Unfortunately, drug metabolism experimental assays are costly, inefficient, and slow. Instead, computational modeling could rapidly flag potentially toxic molecules across thousands of candidates in the early stages of drug development. Most metabolism models focus on predicting sites of metabolism (SOMs): the specific substrate atoms targeted by metabolic enzymes. However, SOMs are merely a proxy for metabolic structures: knowledge of an SOM does not explicitly provide the actual metabolite structure. Without an explicit metabolite structure, computational systems cannot evaluate the new molecule's properties. For example, the metabolite's reactivity cannot be automatically predicted, a crucial limitation because reactive drug metabolites are a key driver of adverse drug reactions (ADRs). Additionally, further metabolic events cannot be forecast, even though the metabolic path of the majority of substrates includes two or more sequential steps. To overcome the myopia of the SOM paradigm, this study constructs a well-defined system-termed the metabolic forest-for generating exact metabolite structures. We validate the metabolic forest with the substrate and product structures from a large, chemically diverse, literature-derived dataset of 20 736 records. The metabolic forest finds a pathway linking each substrate and product for 79.42% of these records. By performing a breadth-first search of depth two or three, we improve performance to 88.43 and 88.77%, respectively. The metabolic forest includes a specialized algorithm for producing accurate quinone structures, the most common type of reactive metabolite. To our knowledge, this quinone structure algorithm is the first of its kind, as the diverse mechanisms of quinone formation are difficult to systematically reproduce. We validate the metabolic forest on a previously published dataset of 576 quinone reactions, predicting their structures with a depth three performance of 91.84%. The metabolic forest accurately enumerates metabolite structures, enabling promising new directions such as joint metabolism and reactivity modeling.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32881497      PMCID: PMC8716321          DOI: 10.1021/acs.jcim.0c00360

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  124 in total

1.  Acute generalized exanthematous pustulosis resembling toxic epidermal necrolysis caused by famotidine.

Authors:  Noah Scheinfeld; Karen Wesson; Patricia Perry; Jeffery Weinberg
Journal:  Acta Derm Venereol       Date:  2003       Impact factor: 4.437

Review 2.  Naturally occurring cyclohexane epoxides: sources, biological activities, and synthesis.

Authors:  José Marco-Contelles; María Teresa Molina; Shazia Anjum
Journal:  Chem Rev       Date:  2004-06       Impact factor: 60.622

3.  Trial watch: phase II and phase III attrition rates 2011-2012.

Authors:  John Arrowsmith; Philip Miller
Journal:  Nat Rev Drug Discov       Date:  2013-08       Impact factor: 84.694

4.  XenoSite: accurately predicting CYP-mediated sites of metabolism with neural networks.

Authors:  Jed Zaretzki; Matthew Matlock; S Joshua Swamidass
Journal:  J Chem Inf Model       Date:  2013-11-23       Impact factor: 4.956

5.  Cytochrome P450 isoforms responsible for the N-deethylation and cyclohexane-hydroxylation of NS-21.

Authors:  A Nakamura; T Hirota; A Morino; S Imaoka; Y Funae; Y Yamamoto; T Tasaki; M Masuda; A Kazusaka; S Fujita
Journal:  Xenobiotica       Date:  1999-03       Impact factor: 1.908

6.  Animal models of idiosyncratic drug reactions.

Authors:  Jacintha M Shenton; Jie Chen; Jack P Uetrecht
Journal:  Chem Biol Interact       Date:  2004-11-01       Impact factor: 5.192

7.  Cardiovascular effects of dipyrone and propofol on hemodynamic function in rabbits.

Authors:  Christine M Baumgartner; Hilke Koenighaus; Johanna K Ebner; Julia Henke; Tibor Schuster; Wolf D Erhardt
Journal:  Am J Vet Res       Date:  2009-11       Impact factor: 1.156

Review 8.  Reducing attrition in drug development: smart loading preclinical safety assessment.

Authors:  Ruth A Roberts; Stefan L Kavanagh; Howard R Mellor; Christopher E Pollard; Sally Robinson; Stefan J Platz
Journal:  Drug Discov Today       Date:  2013-11-21       Impact factor: 7.851

Review 9.  Idiosyncratic adverse drug reactions: current concepts.

Authors:  Jack Uetrecht; Dean J Naisbitt
Journal:  Pharmacol Rev       Date:  2013-03-08       Impact factor: 25.468

10.  Modeling Reactivity to Biological Macromolecules with a Deep Multitask Network.

Authors:  Tyler B Hughes; Na Le Dang; Grover P Miller; S Joshua Swamidass
Journal:  ACS Cent Sci       Date:  2016-07-29       Impact factor: 14.553

View more
  3 in total

1.  Modeling the Bioactivation and Subsequent Reactivity of Drugs.

Authors:  Tyler B Hughes; Noah Flynn; Na Le Dang; S Joshua Swamidass
Journal:  Chem Res Toxicol       Date:  2021-01-26       Impact factor: 3.739

2.  XenoNet: Inference and Likelihood of Intermediate Metabolite Formation.

Authors:  Noah R Flynn; Na Le Dang; Michael D Ward; S Joshua Swamidass
Journal:  J Chem Inf Model       Date:  2020-06-29       Impact factor: 4.956

3.  Bioactivation of Isoxazole-Containing Bromodomain and Extra-Terminal Domain (BET) Inhibitors.

Authors:  Noah R Flynn; Michael D Ward; Mary A Schleiff; Corentine M C Laurin; Rohit Farmer; Stuart J Conway; Gunnar Boysen; S Joshua Swamidass; Grover P Miller
Journal:  Metabolites       Date:  2021-06-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.